Skip to search formSkip to main contentSkip to account menu

BMS 181184

Known as: BMS-181184 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Activity of pradimicin BMS-181184 against Aspergillus spp.
1997
1997
In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
Review
1997
Review
1997
Recent developments in pradimicin-benanomicin and triazole antibiotics.
Fungal infections are on the rise as the number of patients with compromised immune systems continues to increase. The need for… 
1993
1993
BMS-181184, a new pradimicin derivative. Screening, taxonomy, directed biosynthesis, isolation and characterization.
BMS-181184 is a new semisynthetic pradimicin derivative with a broad-spectrum antifungal activity. In a search for actinomycetes… 
1993
1993
Studies on the mode of antifungal action of pradimicin antibiotics. I. Lectin-mimic binding of BMY-28864 to yeast mannan in the presence of calcium.
BMY-28864 (BMS-181184), a water-soluble pradimicin derivative, specifically bound on the yeast cell surface in the presence of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)